
Kangwei Bio
康威生物
Kangwei Bio
Biotech/Healthcare
Kangwei Biotech is focused on developing a new class of drugs, including anticancer drugs and innovative treatments for infertility. Its core team consists of overseas-trained PhDs with independent intellectual property.
Latest round: Series A Extension (2022)
Source: ChinaBulls — chinabulls.com
Last updated 2022-08-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.